Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Navas Acosta JDV
- Hernández Sánchez A
- Villaverde Ramiro Á
- Santos-Mínguez S
- González S
- Rodriguez I
- Miguel-García C
- Cisneros Sala A
- Puiggros A
- Costa D
- Beà S
- Fernández-González R
- Martinez-Laperche C
- Barrena S
- Herrero-Garcia M
- Morgades M
- Sánchez R
- Espinet Sola B
- Granada I
- Orfao A
- Ribera JM
- Benito R
- Hernández-Rivas JM
Grupos
Abstract
Adult B-cell precursor acute lymphoblastic leukemia (B-ALL) is genetically heterogeneous, comprising numerous subtypes. Standard methods leave many patients unclassified, and routine implementation of whole-transcriptome sequencing (WTS) or whole-genome sequencing (WGS) is limited. We evaluated a combined workflow of Optical Genome Mapping (OGM) and targeted next-generation sequencing (t-NGS) for genetic characterization of 100 adult BCR::ABL1-negative B-ALL patients enrolled in PETHEMA-LAL-19. This approach was compared with protocol genetic testing. The integration of OGM and t-NGS enabled the classification of 84% of BCR::ABL1-negative patients into 15 distinct subtypes, reducing the proportion of B-other/unclassified case from 50% to 16%. OGM was useful in identifying BCR::ABL1-like (26% of cases), associated with post-induction minimal residual disease (MRD) positivity (72% vs. 34%, p=0.0011), while t-NGS contributed to the detection of mutation-defined subtypes (PAX5 P80R and PAX5alt), correlated with MRD negativity (91% vs. 51%, p=0.012). OGM and t-NGS identified genetic patterns of certain subtypes, including a higher prevalence of IKZF1plus in BCR::ABL1-like (62% vs. 12%, p<0.001), JAK-STAT mutations only in patients with CRLF2-rearrangements and a high prevalence of PAX5-biallelic events (92% vs. 2%, p<0.001) in PAX5-subtypes. Therefore, the integration of OGM and t-NGS represents a feasible approach that enables comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL, supporting its implementation in routine diagnostic workflows.
Copyright © 2026 American Society of Hematology.
Datos de la publicación
- ISSN/ISSNe:
- 2473-9529, 2473-9537
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 42664485
Blood Advances ELSEVIER
Documentos
- No hay documentos
Filiaciones
Cita
Navas JDV,Hernández A,Villaverde Á,Santos S,González S,Rodriguez I,Miguel C,AVETISYAN G,Cisneros A,Puiggros A,Costa D,Beà S,Fernández R,Martinez C,RIBERA J,Barrena S,Herrero M,Morgades M,Sánchez R,SUCH E,Espinet B,Granada I,Orfao A,Ribera JM,Benito R,Hernández JM. Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS. Blood Adv.
Portal de investigación